Forbes November 6, 2024
A clinical trial of 52 people with long Covid who were prescribed low doses of lithium aspartate revealed that it failed to treat symptoms like chronic fatigue and brain fog. Despite this finding, researchers say higher doses of the medication might offer some relief from long Covid symptoms.
In a press release, lead author of the study, Thomas J. Guttuso, a professor of neurology at the Jacobs School of Medicine and Biomedical Sciences said: “It’s a negative study with a positive twist.”
“This is a very small number of patients, so these findings can only be seen as preliminary. Perhaps achieving higher blood levels of lithium may provide improvements to fatigue and brain fog in long COVID,” Guttuso added.
Guttuso...
Today's Sponsors
Today's Sponsor